The FDA has approved Restylane Contour for improvement of temple hollowing, expanding Galderma's indication portfolio beyond the midface and lips. Temple volume loss is a recognized marker of aging and a common off-label injection site; this approval gives practices a cleared product and removes regulatory ambiguity around the indication.
Injectables
FDA Approves Restylane Contour for Temple Hollowing — Galderma Expands Filler Indication Portfolio
Galderma gains clearance for HA filler in temple region, adding a new anatomical indication to its Restylane platform.
Temple hollowing approval removes regulatory ambiguity from a common off-label injection site.
Operationally, this is incremental for Galderma but meaningful for practices: it adds a distinct, billable treatment area to your Restylane menu, supports patient education (you can now cite FDA approval in consultations), and may drive higher per-session syringe consumption in comprehensive facial rejuvenation plans. Like Skinvive's neck approval, this reflects the industry trend of expanding filler indications beyond traditional zones — practices should expect similar approvals from AbbVie and Evolus as manufacturers seek to differentiate and defend market share.
Source: original report ↗
Frequently asked questions
Is Restylane Contour FDA approved for temples?
Yes, the FDA recently approved Restylane Contour specifically for improvement of temple hollowing, making it the first HA filler with a cleared indication in the temple region. This removes the off-label status and gives practices a regulatory-backed option for this common treatment area.
Can you use Restylane for temple volume loss?
Yes, Restylane Contour is now FDA-cleared for temple hollowing, which is a recognized marker of aging and a common injection site. This approval allows practices to offer temple treatment as a distinct, billable service area within their Restylane menu.
What new indications has Galderma added to Restylane?
Galderma has expanded Restylane's indication portfolio to include temple hollowing, building on existing approvals in the midface and lips. This reflects an industry trend of manufacturers seeking to differentiate their filler platforms by adding new anatomical zones beyond traditional treatment areas.
How does temple filler approval affect medspa revenue?
Temple approval adds a distinct, billable treatment area to your Restylane offerings and typically increases syringe consumption in comprehensive facial rejuvenation plans. It also strengthens patient education, since you can now cite FDA approval in consultations rather than discussing off-label use.
Will other filler brands get temple approvals?
Yes, industry experts expect similar temple and other anatomical approvals from competitors like AbbVie and Evolus as manufacturers expand indications to differentiate and defend market share. This mirrors the recent trend of neck approvals like Skinvive's, signaling a broader shift toward multi-zone filler portfolios.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Seasoned Expat Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.